lomerizine

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2018
024619952018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Migraine is one of the risk factor for ischemic stroke. The purpose of this study was to examine the effect of lomerizine, a… (More)
  • figure 1
  • figure 4
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2010
2010
Secondary degeneration is a process encompassing damage adjacent to a primary injury, usually involving increased Ca(2+) influx… (More)
  • table 1
  • figure 2
Is this relevant?
2009
2009
Secondary degeneration is a form of 'bystander' damage that can affect neural tissue both nearby and remote from an initial… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
PURPOSE After partial optic nerve (ON) injury, intact retinal ganglion cells (RGCs) undergo secondary death, but the topographic… (More)
Is this relevant?
2006
2006
PURPOSE We investigated whether lomerizine, a new diphenylmethylpiperazine calcium channel blocker, exerted a neuroprotective… (More)
Is this relevant?
2003
2003
PURPOSE To investigate the effects of lomerizine, a Ca2+ antagonist, on the ocular tissue circulation in rabbits and on the… (More)
Is this relevant?
2001
2001
We examined the effects of lomerizine, a new diphenylmethylpiperazine Ca2+ channel blocker, on the normal circulation in the… (More)
Is this relevant?
2000
2000
We examined the effects of a new Ca2+ channel blocker, lomerizine, on the intraocular hypertension-induced ischemia/reperfusion… (More)
Is this relevant?
1999
1999
1. In the present study we examined the effects of a new Ca2+ channel blocker (lomerizine), an antimigraine drug, on cerebral… (More)
Is this relevant?
1998
1998
Lomerizine, a novel Ca2+ channel blocker, is under development as an anti-migraine drug. We examined the effects on spreading… (More)
Is this relevant?